diamonds, page-5

best 2006 picks welcome:Here are my top choices for 2006
In financial:MCQUARIE bANK
Telestra in communication
Best Upside in drugs and biotech;Mayne target up 40%
Biotech:Peptech run to $2.20 over next 6 mos.
BTA:If trial goes their way then $3 possible in 6 mos
SRX : My biggest upside surprise i think will be Sirtex Medical; Sirtex is experiencing 100+% revenue and profit growth, and only treating 0.5% of the potential 250,000 patients that could use Sir Spheres with new chemotherapy drugs Irinotecan and Oxaliplatin and other indications from Pfizer and Aventis-Sanofi. Treatment is $14,000 USD per dose and recent approval of funding by Autralian government has not been built in price of share. Also 100%+ growth not yet appreciated by the street. When all this catches up I think share could breakout over $3.75 in next 3 mos. Then there always is nice premium big biotech would pay for shares as there was previous Cephalon bid of $4.75.